SCHEMBL3636443

SCHEMBL3636443

Cc1cccc2[nH]c(=O)n(C3CCN(C[C@H](C)N(Cc4ccccc4)Cc4ccccc4)CC3)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 8/20 0.47
OPRL1 P41146 4/20 0.47
OPRK1 P41145 1/20 0.47
PLD1 Q13393 2/20 0.46
DRD2 P14416 7/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR2C P28335 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
CTSS P25774 1/20 0.44
DRD4 P21917 6/20 0.43
DRD3 P35462 5/20 0.43
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
PLD2 O14939 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3635533 0.89 OPRM1 (0.46) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3630082 0.89 OPRM1 (0.46) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3636808 0.86 OPRM1 (0.65) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3666702 0.86 OPRM1 (0.65) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3636203 0.86 BCHE (0.46) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3634833 0.85 OPRM1 (0.43) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL3639475 0.83 OPRM1 (0.61) OPRM1OPRL1OPRK1PLD1CHRM2
SCHEMBL3635861 0.80 OPRM1 (0.60) OPRM1OPRL1OPRK1PLD1DRD2
SCHEMBL22605916 0.77 OPRM1 (0.54) OPRM1OPRL1OPRK1DRD2CHRM2
SCHEMBL3636335 0.77 OPRM1 (0.63) OPRM1OPRL1OPRK1PLD1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 EP claimed
EP-2150532-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE Evotec AG (DE) 2010-02-10 EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 WO claimed
WO-2008122787-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE EVOTEC AG (DE) 2008-10-16 WO claimed